A&O Shearman advised XGEN Venture, while Ashurst supported British Patient Capital. EpilepsyGTx, a UK‑based biotechnology company focused on the research and development of gene therapies for...
A&O Shearman advised XGEN Venture, while Ashurst supported British Patient Capital. EpilepsyGTx, a UK‑based biotechnology company focused on the research and development of gene therapies for...
